A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy

DSpace/Manakin Repository

A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy

Citable link to this page

. . . . . .

Title: A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy
Author: Paez-Cortez, Jesus; Schmitt-Knosalla, Isabela; Mfarrej, Bechara; Donnarumma, Michela; Habicht, Antje; Clarkson, Michael R.; Ansari, M. Javeed; Yuan, Xueli; D'Addio, Francesca; Iacomini, John J.; Glimcher, Laurie Hollis; Sayegh, Mohamed Hassan

Note: Order does not necessarily reflect citation order of authors.

Citation: Yuan, Xueli, Jesus Paez-Cortez, Isabela Schmitt-Knosalla, Francesca D'Addio, Bechara Mfarrej, Michela Donnarumma, Antje Habicht, et al. 2008. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. The Journal of Experimental Medicine 205(13): 3133-3144.
Full Text & Related Files:
Abstract: T-bet plays a crucial role in Th1 development. We investigated the role of T-bet in the development of allograft rejection in an established MHC class II–mismatched (bm12 into B6) model of chronic allograft vasculopathy (CAV). Intriguingly, and in contrast to IFN-γ−/− mice that are protected from CAV, T-bet−/− recipients develop markedly accelerated allograft rejection accompanied by early severe vascular inflammation and vasculopathy, and infiltration by predominantly IL-17–producing CD4 T cells. Concurrently, T-bet−/− mice exhibit a T helper type 1 (Th1)–deficient environment characterized by profound IFN-γ deficiency, a Th2 switch characterized by increased production of interleukin (IL) 4, IL-5, IL-10, and IL-13 cytokines, as well as increased production of the proinflammatory cytokines IL-6, IL-12p40, and IL-17. Neutralization of IL-17 inhibits accelerated allograft rejection and vasculopathy in T-bet−/− mice. Interestingly, CD4 but not CD8 T cell deficiency in T-bet−/− mice affords dramatic protection from vasculopathy and facilitates long-term graft acceptance. This is the first study establishing that in the absence of Th1-mediated alloimmune responses, CD4 Th17 cells mediate an aggressive proinflammatory response culminating in severe accelerated allograft rejection and vasculopathy. These results have important implications for the development of novel therapies to target this intractable problem in clinical solid organ transplantation.
Published Version: doi:10.1084/jem.20081937
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605226/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4889507

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters